These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7844615)

  • 21. Infusional chemotherapy with new drugs: taxanes, vinorelbine and topoisomerase I inhibitors.
    Dieras V; Pouillart P
    J Infus Chemother; 1995; 5(4):191-2. PubMed ID: 8934724
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
    Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS
    J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
    Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phlebitis after vinorelbine].
    Sauter C; Margulies A; Pestalozzi B
    Schweiz Med Wochenschr; 1998 Feb; 128(9):343. PubMed ID: 9544462
    [No Abstract]   [Full Text] [Related]  

  • 26. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
    Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA
    J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infarct-typical changes in the electrocardiogram following chemotherapy with vinblastine].
    Zeymer U; Neuhaus KL
    Dtsch Med Wochenschr; 1989 Apr; 114(15):589-92. PubMed ID: 2467791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
    Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
    J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The study of cisplatin and vinorelbine in metastatic uterine cervical cancer.
    Kamnerdsupaphon P; Chitapanarux I; Tharavichitkul E; Sukthomya V; Lorvidhaya V
    J Med Assoc Thai; 2009 Jun; 92(6):836-40. PubMed ID: 19530590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer.
    Krainer M; Tomek S; Elandt K; Horak P; Albrecht W; Eisenmenger M; Höltl W; Schramek P; Stackl W; Zielinski C; Reibenwein J
    J Urol; 2007 Jun; 177(6):2141-5; discussion 2145. PubMed ID: 17509302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group.
    Johansen M; Kuttesch J; Bleyer WA; Krailo M; Ames M; Madden T
    Clin Cancer Res; 2006 Jan; 12(2):516-22. PubMed ID: 16428494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and tolerance of Navelbine in phase I-II clinical studies.
    Besenval M; Delgado M; Demarez JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):37-40. PubMed ID: 2540533
    [No Abstract]   [Full Text] [Related]  

  • 35. Vinorelbine: a horse of a different color?
    Pinedo HM; Van Groeningen CJ
    J Clin Oncol; 1994 Sep; 12(9):1745-7. PubMed ID: 8083696
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours.
    Lê LH; Moore MJ; Siu LL; Oza AM; MacLean M; Fisher B; Chaudhary A; de Alwis DP; Slapak C; Seymour L
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):154-60. PubMed ID: 15809877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation recall with vinorelbine and cisplatin.
    Zhu ZF; Fan M; Fu XL
    Onkologie; 2010; 33(3):107-9. PubMed ID: 20215801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.
    George MJ; Heron JF; Kerbrat P; Chauvergne J; Goupil A; Lebrun D; Guastalla JP; Namer M; Bugat R; Ayme Y
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):30-2. PubMed ID: 2652318
    [No Abstract]   [Full Text] [Related]  

  • 40. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.